and Wegovy for weight management, with significantly higher nausea rates of approximately 44% in clinical trials), as well as oral formulation Rybelsus (approximately 20% nausea incidence)
Phase 2 trials have shown impressive results, and a recently published phase 3 trial had even better findings
The two medications have different dose schedules, different side-effect profiles, and different insurance coverage pathways
His alcohol cravings had reduced significantly
It is typically used to treat joint pain, arthritis, ligament and tendon injuries, post-surgical recovery, nerve problems, and digestive issues such as IBD or leaky gut
At Prescription Weight Loss Inc., we provide guidance on nutrition, physical activity, and behavior changes to maximize your success